Since its first trial in 2019, Israel’s Active Implants (see here previously) has performed nearly 1,000 implants of its NUsurface synthetic meniscus in Israel and Europe. It expects FDA approval to allow launch in the US in 2024. https://www.youtube.com/watch?v=tB8aWsXbGhg https://www.israel21c.org/new-hope-for-people-who-kneed-a-new-meniscus/

Israeli doctors performed the first commercial replacement surgery of the meniscus (knee cartilage) on two Israeli patients. Via a small incision, they each received the NUsurface artificial meniscus implant developed at the Netanya, Israel R&D center of US company Active … Continue reading →

Active Implants, whose R&D center is in Netanya Israel, is looking for patients in Israel and Europe willing to join the trial of its NUsurface Meniscus Implant. The novel, composite polymer implant is for osteoarthritis patients who have pain and … Continue reading →